Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

David Feller Kopman

Critical Care Medicine Baltimore, MD Medical Doctor

NPI 1801885967 CMS profile 172173

600 N Wolfe St, 1830 Bldg. 5Th Floor, Baltimore, MD 21287

Open in the dashboard

General payments

$236,414

196 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$17,556 paid to institutions, not to them · program years 2019–2021

Through program year 2025, David Feller Kopman of Baltimore, MD is reported in the CMS Open Payments database as having received $236,414 across 196 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $17,556 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Critical Care Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,050 2
2024 General $5,117 7
2023 General $3,055 8
2022 General $40,919 29
2021 General $20,974 22
2020 General $35,854 28
2019 General $129,445 100

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • David Feller Kopman
  • Critical Care Medicine median
  • Middle half of Critical Care Medicine
  • National median

In program year 2025, general payments to David Feller Kopman were reported at $1,050. Among 2,664 Critical Care Medicine profiles paid that year, the median was $189 and the middle half received between $59 and $844.

Show as a table
Year David Feller Kopman Critical Care Medicine median Middle half National median
2019 $129,445 $149 $51–$535 $163
2020 $35,854 $110 $30–$325 $114
2021 $20,974 $125 $34–$403 $132
2022 $40,919 $157 $49–$582 $149
2023 $3,055 $162 $56–$621 $160
2024 $5,117 $168 $53–$634 $164
2025 $1,050 $189 $59–$844 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AstraZeneca Pharmaceuticals LP $134,130 106 payments
  2. Ambu A/S $32,162 5 payments
  3. AstraZeneca UK Limited $19,563 14 payments
  4. Daiichi Sankyo Inc. $12,210 11 payments
  5. Veran Medical Technologies, Inc. $10,850 9 payments
  6. Boston Scientific Corporation $5,235 5 payments
  7. Intuitive Surgical, Inc. $4,420 9 payments
  8. Cook Incorporated $4,400 1 payment
  9. Merit Medical Systems Inc $4,213 8 payments
  10. Bard Peripheral Vascular, Inc. $2,744 6 payments
  11. Other $6,489 22 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $114,201 52 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $89,400 42 payments
  3. Travel and Lodging $20,550 48 payments
  4. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $4,400 1 payment
  5. Food and Beverage $3,820 50 payments
  6. Education $3,000 1 payment
  7. Honoraria $1,000 1 payment
  8. Gift $43 1 payment
Products named General payments · program years 2019–2025
  1. IMFINZI Cardiovascular And Metabolism $100,419 80 payments
  2. IMFINZI Oncology $13,134 13 payments
  3. IMFINZI Oncology $12,429 14 payments
  4. ENHERTU $11,680 10 payments
  5. Spin $10,850 9 payments
  6. TAGRISSO $10,508 5 payments
  7. GENERAL PULMONARY $5,042 3 payments
  8. Da Vinci Surgical System $4,420 9 payments
  9. Cook Medical Ciaglia Blue Rhino $4,411 2 payments
  10. FUJIFILM $2,300 2 payments
  11. Other $4,921 22 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 56 billing codes

Paid by Medicare

$68,346

Medicare's payments for the services billed

Medicare patients

249

Average age 73

Services billed

798

129 women, 120 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
COPD 52%
Ischemic heart disease 45%
Cancer 43%
Arthritis 41%
Heart failure 39%
Diabetes 37%
Atrial fibrillation 35%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

196 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Critical Care Medicine in Maryland

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record